Skip to content

Ovarian Cancer Screening Biomarker Profile (Selected Tests)

Published: August 9, 2026Updated: August 16, 2026

This test measures specific blood markers that may help assess risk or monitor ovarian cancer. It’s often used in conjunction with clinical evaluation for women at higher risk or during follow-up.

Quick summary

["This panel helps identify markers linked to ovarian cancer, aiding early detection or monitoring in certain cases."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
57179-4
Short code
OBGYN Referral note
Synonyms
OBGYN Referral note
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
obstetrics-and-gynecology
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The test includes a selection of biomarkers, such as **CA-125** (Cancer Antigen 125), which is commonly elevated in ovarian cancer, and other potential markers depending on the specific panel. These tests are typically performed on **serum/plasma** blood samples.

Why It’s Performed

Your healthcare provider may order this test if you have a family history of ovarian cancer, symptoms like bloating or pelvic pain, or if you’re undergoing surveillance for ovarian cancer. It may also be part of a broader evaluation for gynecologic conditions.

What to Expect Before the Test

No special preparation is usually needed. You’ll have a small needle inserted into your arm to draw blood. This process takes about 5 minutes. If you’re on blood thinners, inform your provider beforehand.

What the Results Mean

Results vary by marker. For example, **CA-125** levels may be higher in ovarian cancer, but they can also rise in other conditions like endometriosis or benign cysts. Your doctor will interpret results in the context of your medical history and symptoms.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

Ovarian Cancer Biomarker Panel

Frequently asked questions

This test is not a definitive diagnostic tool for ovarian cancer but can support screening or monitoring. It’s often used alongside imaging studies (like ultrasounds) and clinical assessments to guide further evaluation.
This test may not detect all ovarian cancers, especially in the early stages. False positives can also occur, so results should be reviewed by a healthcare provider.
If I have symptoms like bloating or pelvic pain, should I get this test immediately?
Not necessarily. Symptoms can be caused by many conditions, including non-cancerous ones. Your doctor will evaluate your symptoms and may recommend this test as part of a broader evaluation, especially if you have risk factors.
Can I fast before this blood test?
No fasting is required for this test. However, if your doctor has specific instructions (e.g., for other tests included in your panel), follow those instead.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy